IndraLab

Statements


2 | 1

No evidence text available

No evidence text available

reach
"In addition, the MKI sunitinib, which potently inhibited TAK1 activity (IC50 = 0.16 microM; XREF_FIG), displayed high affinity for TAK1 in situ (XREF_FIG)."